By Counterforce Health Team in Tavalisse (fostamatinib disodium hexahydrate) —

How to Get Tavalisse (fostamatinib) Covered by UnitedHealthcare in New Jersey: Complete Guide with Forms and Appeal Scripts

Answer Box: Getting Tavalisse Covered by UnitedHealthcare in New Jersey

Fastest Path to Approval: UnitedHealthcare requires prior authorization for Tavalisse (fostamatinib) with step therapy documentation. You'll need proof of failed corticosteroids and typically a thrombopoietin receptor agonist, plus platelet counts <30,000/μL documented by a hematologist. Submit via the UHC Provider Portal with complete clinical records. If denied, New Jersey's IHCAP external review through Maximus Federal Services offers binding decisions within 45 days. Start today: Contact your hematologist to document prior therapy failures and current platelet counts.

Table of Contents

  1. Understanding UnitedHealthcare's Tavalisse Coverage
  2. Pre-Authorization Requirements
  3. Step-by-Step: Fastest Path to Approval
  4. Common Denial Reasons & How to Fix Them
  5. New Jersey Appeals Process
  6. Patient Assistance and Cost Support
  7. Clinician Corner: Medical Necessity Documentation
  8. When to Escalate: External Review
  9. FAQ
  10. Sources & Further Reading

Understanding UnitedHealthcare's Tavalisse Coverage

Tavalisse (fostamatinib disodium hexahydrate) is an oral SYK inhibitor approved for adults with chronic immune thrombocytopenia (ITP) who haven't responded adequately to previous treatments. At approximately $14,000-$16,000 per 60-tablet bottle, this specialty medication requires careful navigation of UnitedHealthcare's coverage requirements.

UnitedHealthcare, through its pharmacy benefit manager OptumRx, classifies Tavalisse as a specialty drug requiring prior authorization and step therapy compliance. The good news? With proper documentation and persistence, many patients successfully obtain coverage—especially in New Jersey, where state law provides robust external appeal rights.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required Must get approval before dispensing UHC PA Requirements OptumRx Policy
Step Therapy Must try/fail preferred drugs first Formulary guidelines UHC Formulary
Hematologist Required Diagnosis must be by blood specialist Clinical documentation UHC Medical Policy
Platelet Threshold Usually <30,000/μL documented Lab results required Clinical Guidelines
Appeals Deadline 180 days from denial (internal) Member handbook UHC Policy
NJ External Review 4 months from final denial IHCAP program NJ DOBI

Pre-Authorization Requirements

UnitedHealthcare's 2024 requirements for Tavalisse are specific and strictly enforced. Here's what you need to gather:

Clinical Documentation Required:

  • Confirmed diagnosis of chronic ITP by a board-certified hematologist
  • Complete blood count showing isolated thrombocytopenia (platelets <100,000/μL, typically <30,000/μL for treatment)
  • Peripheral blood smear excluding other conditions
  • Documentation ruling out secondary causes (hepatitis C, HIV, medications)

Prior Therapy Documentation:

  • Detailed record of corticosteroid trial (dose, duration, response, reason for discontinuation)
  • Evidence of thrombopoietin receptor agonist (TPO-RA) trial or contraindication
  • Any other ITP treatments attempted (IVIG, rituximab, etc.)

Supporting Evidence:

  • Current platelet count and trend over time
  • Bleeding symptoms or risk factors
  • Treatment goals and expected outcomes
  • Contraindications to preferred formulary alternatives
Tip: Start gathering this documentation early. The most common cause of delays is incomplete prior therapy records, especially from previous providers or health systems.

Step-by-Step: Fastest Path to Approval

Step 1: Confirm Diagnosis and Eligibility (Week 1)

Who: Hematologist
What: Document chronic ITP diagnosis per accepted criteria
Submit: Clinical notes with ICD-10 code D69.3
Timeline: Same day

Step 2: Document Prior Therapies (Week 1-2)

Who: Clinical staff
What: Compile complete treatment history with outcomes
Submit: Treatment summaries with dates, doses, responses
Timeline: 3-5 business days

Step 3: Submit Prior Authorization (Week 2)

Who: Provider or staff
What: Complete PA request via UHC Provider Portal
Submit: UnitedHealthcare Provider Portal
Timeline: Submit 3-4 weeks before needed medication

Step 4: Track and Follow Up (Week 3)

Who: Clinical staff
What: Monitor PA status and respond to requests
Submit: Additional documentation as requested
Timeline: Check status every 2-3 business days

Step 5: Review Decision (Week 3-4)

Who: Provider and patient
What: Analyze approval or prepare appeal
Submit: Appeal documents if denied
Timeline: Within 72 hours for standard determination

Step 6: Peer-to-Peer Review (If Needed)

Who: Prescribing physician
What: Direct discussion with UHC medical director
Submit: Clinical justification via phone
Timeline: Schedule within 24-48 hours of denial

Step 7: File Appeal (If Necessary)

Who: Provider or patient
What: Formal written appeal with new evidence
Submit: UHC appeals process or NJ external review
Timeline: 180 days for internal, 4 months for external

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
"Prior therapies not documented" Submit complete treatment records Detailed therapy logs with dates, doses, outcomes
"Step therapy not met" Prove TPO-RA failure or contraindication Clinical notes showing adverse effects or lack of response
"Not prescribed by hematologist" Transfer care or get consultation Referral to board-certified hematologist
"Platelet count not severe enough" Document bleeding risk or symptoms Current CBC, bleeding history, quality of life impact
"Diagnosis not confirmed" Strengthen diagnostic workup Bone marrow biopsy (if done), comprehensive lab panel
"Alternative treatments available" Show contraindications to alternatives Allergy history, drug interactions, previous failures

New Jersey Appeals Process

New Jersey offers one of the strongest external review programs in the country through the Independent Health Care Appeals Program (IHCAP).

Internal Appeals with UnitedHealthcare:

  • Timeline: 180 days from denial
  • Levels: Typically 2 internal levels required
  • Expedited: 24-72 hours if urgent medical need
  • Submit: UHC member portal or written appeal

External Review through IHCAP:

  • Administered by: Maximus Federal Services
  • Eligibility: After completing internal appeals
  • Timeline: 4 months from final internal denial
  • Decision: Within 45 days (48 hours if expedited)
  • Cost: Free to patient/provider
  • Binding: Yes, on both parties

How to File External Appeal:

  1. Visit njihcap.maximus.com
  2. Complete online appeal form
  3. Upload denial letters and medical records
  4. Include physician letter explaining medical necessity
  5. Request expedited review if medically urgent
Note: New Jersey's external review success rate for specialty drugs is approximately 50-60%, making it a viable option for denied Tavalisse requests.

Patient Assistance and Cost Support

RIGEL ONECARE Program:

  • Copay Support: Pay as little as $15/prescription (commercial insurance only)
  • Patient Assistance: Free drug for qualifying uninsured patients
  • Bridge Therapy: Coverage during insurance transitions
  • Contact: 1-833-744-3562 (Monday-Friday, 8 AM-8 PM ET)

Eligibility Requirements:

  • Commercial insurance (no Medicare/Medicaid for copay cards)
  • Income limits apply for patient assistance program
  • U.S. residency required

When navigating complex insurance approvals and appeals, many patients and providers find value in specialized support. Counterforce Health helps turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to identify the specific denial basis and draft point-by-point rebuttals aligned to the plan's own rules.

Clinician Corner: Medical Necessity Documentation

Essential Elements for Medical Necessity Letter:

  1. Patient Problem: Clear ITP diagnosis with current platelet count
  2. Prior Treatments: Detailed history of failed therapies with specific outcomes
  3. Clinical Rationale: Why Tavalisse is uniquely appropriate
  4. Guideline Support: Reference to ASH guidelines or other recognized standards
  5. Monitoring Plan: How you'll track safety and efficacy
  6. Treatment Goals: Specific platelet targets and quality of life improvements

Key Clinical References:

  • FDA prescribing information for Tavalisse
  • American Society of Hematology (ASH) ITP guidelines
  • International consensus report on ITP management

Peer-to-Peer Review Script: "This patient has chronic ITP with platelets consistently below 20,000 despite adequate trials of prednisone and eltrombopag. They experienced significant side effects from steroids and inadequate response to TPO receptor agonists. Tavalisse represents a mechanistically different approach with demonstrated efficacy in this exact clinical scenario. The FDA approval was based on patients who failed prior therapies, which matches this case precisely."

When to Escalate: External Review

Consider escalating to New Jersey's external review when:

  • Internal appeals are exhausted or delayed beyond timelines
  • Medical urgency requires expedited decision
  • Plan appears to be misapplying its own coverage policies
  • Strong clinical evidence supports medical necessity

External Review Success Factors:

  • Complete medical records showing ITP diagnosis
  • Detailed prior therapy documentation
  • Strong physician letter explaining medical necessity
  • Current laboratory values and clinical status
  • Reference to published clinical guidelines

The external review process through Counterforce Health's platform can help ensure all required documentation is properly organized and presented to maximize chances of reversal.

FAQ

How long does UnitedHealthcare prior authorization take for Tavalisse in New Jersey? Standard determination within 72 hours of receiving complete documentation. Expedited reviews (for urgent medical need) within 24 hours.

What if Tavalisse isn't on my UHC formulary? File a formulary exception request with medical necessity documentation. Include evidence that formulary alternatives are inappropriate due to contraindications or previous failures.

Can I request expedited review for Tavalisse approval? Yes, if delay would seriously jeopardize your health. Your physician must provide supporting documentation of urgent medical need.

Does New Jersey step therapy apply if I failed treatments in another state? Yes, prior therapy documentation from any state counts toward step therapy requirements. Ensure records are transferred to your New Jersey hematologist.

What happens if UnitedHealthcare approves but limits the quantity? Quantity limits can be appealed separately. Your physician should document the medical necessity for the prescribed quantity and frequency.

How much does the New Jersey external review cost? The IHCAP external review is completely free to patients and providers. UnitedHealthcare pays all costs associated with the independent review.

Can my doctor file the external appeal for me? Yes, providers can file external appeals on behalf of patients with proper consent. This is often more effective as they can provide clinical context directly.

What if I need Tavalisse while my appeal is pending? Contact RIGEL ONECARE at 1-833-744-3562 for potential bridge therapy. Some patients qualify for temporary free medication during appeals.

From our advocates: We've seen several New Jersey patients successfully obtain Tavalisse coverage after initial denials by focusing on the specific step therapy requirements in their UHC plan documents. One key strategy is requesting the exact policy language UHC used for denial, then systematically addressing each criterion with clinical evidence. This approach helped overturn 3 out of 4 denials we tracked, though individual results vary and depend on specific clinical circumstances.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual circumstances and specific plan benefits. Always consult with your healthcare provider and insurance plan directly. For additional support with insurance appeals and coverage issues, contact the New Jersey Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.